Executive Training and Brain in Adolescent

NCT ID: NCT03084848

Last Updated: 2019-07-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-18

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the cognitive and brain effects of inhibitory control (IC) training at adolescence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Brain imaging now allows to study non-invasively cognitive learning processes. An area of strong scientific interest is the development of executive control, an essential cognitive domain for academic and professional success and for mental and physical health. These functions are essentially located within the prefrontal cortex, characterising by a late maturation until the end of adolescence and, while under genetic control, can likely be improved with targeted interventions. The objective of this project is simple and innovative: testing in adolescents with the most appropriate brain imaging technologies available today (the Magnetic Resonance Imaging, MRI), the effect of an executive training focused on the inhibitory control (IC). This project aims at precisely testing the effect at the cognitive and brain levels of IC training in adolescence. To do this, the investigators will recruit two groups of 30 teenagers aged 16 to 17 years old, each assigned to one of two learning situations: IC vs Active Control (AC). Each participant will participate in 25 training sessions of 15 minutes per day, 5 days a week for a month. Brain structural and functional differences in the brain and between the pre-test and post-test related to intense IC training will be correlated with cognitive progress.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active control

Group Type EXPERIMENTAL

Training

Intervention Type OTHER

25 training sessions of 15 minutes per day, 5 days a week for a month of crystallised intelligence

Inhibitor control

Group Type EXPERIMENTAL

Training

Intervention Type OTHER

25 training sessions of 15 minutes per day, 5 days a week for a month of inhibitory control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training

25 training sessions of 15 minutes per day, 5 days a week for a month of crystallised intelligence

Intervention Type OTHER

Training

25 training sessions of 15 minutes per day, 5 days a week for a month of inhibitory control

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 16-17 years old
* girl or boy ;
* French mother tongue;
* Handedness: Right;
* Schooled in a level corresponding to its age (2nd or 1st)
* Informed consent signed by the (s) holder (s) of parental authority, in agreement with the teenager
* Normal medical, neurological, neuroradiological examinations.
* Health insurance

Exclusion Criteria

* Has chronic use of alcohol or drugs;
* Abuse or substance dependence (excluding nicotine) or a toxic over 5 years or has led to comas (overdoses)
* Cognitive disorders of sudden onset that may reflect a stroke; history of head trauma with loss of consciousness for more than 1 hour, or encephalitis;
* A chronic neurological disorder, psychiatric, endocrine, hepatic and infectious disorder;
* Major disease history (diabetes, chronic lung disease, heart disorder, metabolic, hematologic, endocrine or immunological severe cancer);
* A medication that may interfere with brain imaging measures (psychotropic drugs, hypnotics, anxiolytics, antipsychotics, anti-Parkinson, benzodiazepines, anti-inflammatory drugs, antiepileptics, antihistamines, analgesics and muscle relaxants central);
* dyschromatopsia
* Impossibility to submit itself to the study for geographical or psychiatric reasons;
* Pregnant and lactating women;
* Has pervasive developmental disorders and / or acquisitions identified by parents or legal guardian and (or) the teachers;
* Cerebral palsy;
* Fine motor disorder
* Unaccompanied by parent (s) (s) or at least a person with parental authority during the visit to the research platform;
* Tattoo on the head, neck or shoulders
Minimum Eligible Age

16 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre National de la Recherche Scientifique, France

OTHER

Sponsor Role collaborator

Centre Hospitalier St Anne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Catherine OPPENHEIM

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Sainte-Anne

Arnaud Cachia, PhD, Pr

Role: STUDY_DIRECTOR

University Paris Descartes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de Recherche Clinique (CRC) - CHSA

Paris, , France

Site Status

Centre Hospitalier Sainte-Anne

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Ahr E, Houde O, Borst G. Inhibition of the mirror generalization process in reading in school-aged children. J Exp Child Psychol. 2016 May;145:157-65. doi: 10.1016/j.jecp.2015.12.009. Epub 2016 Jan 27.

Reference Type BACKGROUND
PMID: 26827098 (View on PubMed)

Cachia A, Borst G, Vidal J, Fischer C, Pineau A, Mangin JF, Houde O. The shape of the ACC contributes to cognitive control efficiency in preschoolers. J Cogn Neurosci. 2014 Jan;26(1):96-106. doi: 10.1162/jocn_a_00459. Epub 2013 Aug 5.

Reference Type BACKGROUND
PMID: 23915057 (View on PubMed)

Borst G, Cachia A, Vidal J, Simon G, Fischer C, Pineau A, Poirel N, Mangin JF, Houde O. Folding of the anterior cingulate cortex partially explains inhibitory control during childhood: a longitudinal study. Dev Cogn Neurosci. 2014 Jul;9:126-35. doi: 10.1016/j.dcn.2014.02.006. Epub 2014 Feb 27.

Reference Type BACKGROUND
PMID: 24642370 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-A00811-48

Identifier Type: OTHER

Identifier Source: secondary_id

D15-P017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.